1. Home
  2. RMD vs EQR Comparison

RMD vs EQR Comparison

Compare RMD & EQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMD
  • EQR
  • Stock Information
  • Founded
  • RMD 1989
  • EQR 1993
  • Country
  • RMD United States
  • EQR United States
  • Employees
  • RMD N/A
  • EQR N/A
  • Industry
  • RMD Medical/Dental Instruments
  • EQR Real Estate Investment Trusts
  • Sector
  • RMD Health Care
  • EQR Real Estate
  • Exchange
  • RMD Nasdaq
  • EQR Nasdaq
  • Market Cap
  • RMD 31.8B
  • EQR 27.2B
  • IPO Year
  • RMD 1995
  • EQR 1993
  • Fundamental
  • Price
  • RMD $243.58
  • EQR $70.03
  • Analyst Decision
  • RMD Buy
  • EQR Buy
  • Analyst Count
  • RMD 13
  • EQR 16
  • Target Price
  • RMD $259.40
  • EQR $78.44
  • AVG Volume (30 Days)
  • RMD 1.2M
  • EQR 2.0M
  • Earning Date
  • RMD 04-23-2025
  • EQR 04-29-2025
  • Dividend Yield
  • RMD 0.87%
  • EQR 3.93%
  • EPS Growth
  • RMD 37.08
  • EQR 8.50
  • EPS
  • RMD 8.91
  • EQR 2.62
  • Revenue
  • RMD $5,021,529,000.00
  • EQR $3,010,100,000.00
  • Revenue This Year
  • RMD $10.15
  • EQR $6.07
  • Revenue Next Year
  • RMD $7.50
  • EQR $4.33
  • P/E Ratio
  • RMD $27.33
  • EQR $26.96
  • Revenue Growth
  • RMD 9.54
  • EQR 3.81
  • 52 Week Low
  • RMD $179.42
  • EQR $59.41
  • 52 Week High
  • RMD $263.05
  • EQR $78.83
  • Technical
  • Relative Strength Index (RSI)
  • RMD 67.04
  • EQR 51.82
  • Support Level
  • RMD $237.00
  • EQR $69.62
  • Resistance Level
  • RMD $247.35
  • EQR $71.04
  • Average True Range (ATR)
  • RMD 5.41
  • EQR 1.20
  • MACD
  • RMD 1.85
  • EQR 0.16
  • Stochastic Oscillator
  • RMD 90.16
  • EQR 37.96

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

About EQR Equity Residential of Beneficial Interest

Equity Residential owns a portfolio of 311 apartment communities with around 84,000 units and is developing two additional properties with 655 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.

Share on Social Networks: